Vergo Pharma Research Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 23-10-2024
- Paid Up Capital ₹ 0.10 M
as on 23-10-2024
- Company Age 14 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.90 Cr
as on 23-10-2024
- Revenue 59.10%
(FY 2023)
- Profit 580.71%
(FY 2023)
- Ebitda 221.62%
(FY 2023)
- Net Worth 44.60%
(FY 2023)
- Total Assets 43.67%
(FY 2023)
About Vergo Pharma Research
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹2.90 Cr.
Prasad Keni, Vini Keni, Praveen Khullar, and One other member serve as directors at the Company.
- CIN/LLPIN
U73100GA2010PTC014001
- Company No.
014001
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Sep 2010
- Date of AGM
20 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Goa
Industry
Company Details
- Location
Goa, Goa, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Vergo Pharma Research?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Prasad Keni  | Managing Director | 23-Sep-2010 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Kashyap Keni | Director | 19-Sep-2019 | Current |
| Praveen Khullar | Director | 20-Aug-2024 | Current |
| Vini Keni | Director | 23-Sep-2010 | Current |
Financial Performance and Corporate Structure Insights of Vergo Pharma Research.
Vergo Pharma Research Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 59.1% increase. The company also saw a substantial improvement in profitability, with a 580.71% increase in profit. The company's net worth Soared by an impressive increase of 44.6%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Vergo Pharma Research?
In 2023, Vergo Pharma Research had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Vergo Pharma Research Laboratories Private LimitedActive 14 years 4 monthsPrasad Keni, Vini Keni and 2 more are mutual person
V.G. Quenim Mining Private Limited.Active 31 years 7 monthsPrasad Keni, Vini Keni and 1 more are mutual person
- Vilman Healthcare Private LimitedActive 39 years 5 months
Prasad Keni, Vini Keni and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Tata Capital Financial Services Limited Creation Date: 29 Nov 2022 | ₹2.90 Cr | Open |
How Many Employees Work at Vergo Pharma Research?
Vergo Pharma Research has a workforce of 126 employees as of Apr 17, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vergo Pharma Research, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vergo Pharma Research's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
